Payments to Acquire Property, Plant, and Equipment of Allogene Therapeutics, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Allogene Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Allogene Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $99,000, a 1138% increase year-over-year.
  • Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $386,000, a 44% decline from 2024.
  • Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $694,000, a 54% decline from 2023.
  • Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,516,000, a 71% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Allogene Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $386,000 -$308,000 -44% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $694,000 -$822,000 -54% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 $1,516,000 -$3,675,000 -71% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $5,191,000 -$16,255,000 -76% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $21,446,000 -$44,512,000 -67% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $65,958,000 +$15,167,000 +30% 01 Jan 2020 31 Dec 2020 10-K/A 14 Mar 2024 2022 FY
2019 $50,791,000 +$47,557,000 +1471% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $3,234,000 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY

Allogene Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $99,000 +$91,000 +1138% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $8,000 -$1,027,000 -99% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $1,035,000 -$867,000 -46% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $1,902,000 -$4,559,000 -71% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $6,461,000 -$5,792,000 -47% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $12,253,000 +$1,830,000 +18% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $10,423,000 +$10,423,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $0 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q4 2017 $0 30 Nov 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.